Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes

BACKGROUND: Despite the number of medications for type 2 diabetes, many people with the condition do not achieve good glycaemic control. Some existing glucose-lowering agents have adverse effects such as weight gain or hypoglycaemia. Type 2 diabetes tends to be a progressive disease, and most patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Clar, Christine, Gill, James Alexander, Court, Rachel, Waugh, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2012
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488745/
https://www.ncbi.nlm.nih.gov/pubmed/23087012
http://dx.doi.org/10.1136/bmjopen-2012-001007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488745/
https://www.ncbi.nlm.nih.gov/pubmed/23087012
http://dx.doi.org/10.1136/bmjopen-2012-001007

Ejemplares similares